
PEP buys New Zealand's Manuka Health, Waterman exits
Pacific Equity Partners (PEP) has acquired health foods business Manuka Health New Zealand for an undisclosed sum. The deal facilitates an exit for New Zealand-based GP Waterman Capital.
Manuka Health was founded in 2006 by CEO Kerry Paul in response to growing demand for premium manuka honey. It claims to be the first company globally to establish a scientific certification system for the honey, which is used to manufacture dietary supplements, gourmet foods, and personal care and wound care products.
Waterman, operating through its 2010 vintage second fund, which has a corpus of NZ$83 million ($52 million), acquired a 20% stake in Manuka Health in 2012. It provided expansion capital for a number of growth initiatives that resulted in a tripling in production volume following the construction of a new processing facility, a quadrupling in staff numbers, and R&D investment in product development.
Revenue grew from NZ$17 million in 2012 to approximately NZ$70 million for the current financial year, Waterman said in a statement.
Under PEP's ownership, the company will continue to expand internationally. It is already presence in more than 40 countries but has identified China, the US, Australia, New Zealand and Japan as key growth markets. There will also be product category expansion in the wound and personal care segments.
"Manuka Health is an exceptional business in the high growth natural healthcare sector which is underpinned by a number of compelling macro trends including increasing nutritional health awareness and a rise in consumer affluence," David Brown, managing director at PEP, said in a statement.
PEP has previously in consumer products businesses such as Griffin's Foods, Tegel Enterprises, Frucor and Peters Ice Cream. The GP - which is expected to announce a final close of $2.1 billion on its fifth fund imminently - was recently linked to another New Zealand-based asset, Academic Colleges Group.
The Manuka Health deal still requires approval from New Zealand's Overseas Investment Office. PwC and Chapman Tripp advised Manuka Health on the transaction, while PEP worked with UBS and Russell McVeagh.
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.